News: The Best Drug Companies Of 2020

A report from Timothy Anderson at Sanford C. Bernstein examines what will happen to Big Pharma after patents, like the loss of Lipitor from Pfizer and Zyprexa from Eli Lilly, will expire.
June 30, 2011

A report from Timothy Anderson at Sanford C. Bernstein examines what will happen to Big Pharma after patents, like the loss of Lipitor from Pfizer and Zyprexa from Eli Lilly, will expire.

To read the findings of the report visit here.

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates